1. Home
  2. SAM vs QURE Comparison

SAM vs QURE Comparison

Compare SAM & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Beer Company Inc. (The)

SAM

Boston Beer Company Inc. (The)

HOLD

Current Price

$220.49

Market Cap

2.2B

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$25.17

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAM
QURE
Founded
1984
1998
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
1995
2007

Fundamental Metrics

Financial Performance
Metric
SAM
QURE
Price
$220.49
$25.17
Analyst Decision
Hold
Strong Buy
Analyst Count
10
12
Target Price
$243.78
$58.55
AVG Volume (30 Days)
152.4K
1.7M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
23.12
N/A
EPS
8.25
N/A
Revenue
$1,981,609,000.00
$15,751,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.55
$142.93
P/E Ratio
$26.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$185.34
$7.76
52 Week High
$260.00
$71.50

Technical Indicators

Market Signals
Indicator
SAM
QURE
Relative Strength Index (RSI) 63.97 54.62
Support Level $204.94 $21.64
Resistance Level $224.89 $23.34
Average True Range (ATR) 6.18 1.72
MACD 1.67 0.36
Stochastic Oscillator 83.12 51.64

Price Performance

Historical Comparison
SAM
QURE

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: